1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies

Technology appraisal guidance [TA171] Published date: 18 June 2009 Last updated: 26 June 2019

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...

Information for the public


  • Lenalidomide for multiple myeloma in people who have had previous treatment PDF 149.8 KB 18 June 2009  
  • Gwybodaeth i'r cyhoedd Word 240.5 KB 16 November 2009